欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-JAK/STAT Signaling-JAK-Jaktinib hydrochloride
Jaktinib hydrochloride

Chemical Structure : Jaktinib hydrochloride

CAS No.: 2056097-82-4

Jaktinib hydrochloride (Gecacitinib, Momelotinib-3,3,5,5-d4)

货号: PC-27965Not For Human Use, Lab Use Only.

Jaktinib hydrochloride (Gecacitinib, Momelotinib-3,3,5,5-d4) is a deuterated form of momelotinib and selective JAK1/2 inhibitor with IC50 of 0.1 μM on cells transformed by selected oncogenic mutants of tyrosine kinases, inhibits activity of JAK1, JAK2, JAK3, and TYK2, blocks the JAK-STAT signaling pathway.

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

Jaktinib hydrochloride (Gecacitinib, Momelotinib-3,3,5,5-d4) is a deuterated form of momelotinib and selective JAK1/2 inhibitor with IC50 of 0.1 μM on cells transformed by selected oncogenic mutants of tyrosine kinases, inhibits activity of JAK1, JAK2, JAK3, and TYK2, blocks the JAK-STAT signaling pathway.

物理化学性质&存储条件

分子量 454.95
分子式 C23H19D4ClN6O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(Cyanomethyl)-4-(2-((4-(morpholino-3,3,5,5-d4)phenyl)amino)pyrimidin-4-yl)benzamide hydrochloride

参考文献

1. Jingrui Liu, et al. Front Pharmacol. 2020 Dec 14:11:604314.

2. Zhang Y, et al. Blood Cancer J. 2024 Dec 18;14(1):216.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: